Business News • PR NewsWire • VeroScience Continues Clinical Evaluation of Bromocriptine-QR (Cycloset) and Neurophysiological Investigations of Brain Dopamine Regulation of Metabolism with Eight Papers Presented at the 2015 American Diabetes Association Conference

VeroScience Continues Clinical Evaluation of Bromocriptine-QR (Cycloset) and Neurophysiological Investigations of Brain Dopamine Regulation of Metabolism with Eight Papers Presented at the 2015 American Diabetes Association Conference

VeroScience Continues Clinical Evaluation of Bromocriptine-QR (Cycloset) and Neurophysiological Investigations of Brain Dopamine Regulation of Metabolism with Eight Papers Presented at the 2015 American Diabetes Association Conference

TIVERTON, R.I., June 6, 2015 /PRNewswire/ -- VeroScience, Inc. is pleased to be participating at the American Diabetes Association's 75th Scientific Sessions in Boston, Mass with additional clinical data on circadian-timed morning administration of bromocriptine-QR (Cycloset), a...

View More : http://www.prnewswire.com/news-releases/veroscience-continues-clinical-evaluation-of-bromocriptine-qr-cycloset-and-neuro...

Releted News by prnewswire

Disruption in Access to Diabetes Monitoring Supplies Leads to Increased Hospitalizations, Mortality Among Medicare Beneficiaries

Sanofi's Lyxumia® (lixisenatide) Statistically Superior to Rapid Acting Insulin for Body Weight Change with Similar Blood Sugar Control when Both are Added to Basal Insulin

Mohed Altrad of Altrad Group from France named EY World Entrepreneur Of The Year 2015

iTeknik Holding Corporation Seeks Acquisitions to Start New Expansion Program